CN106383191B - The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine - Google Patents

The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine Download PDF

Info

Publication number
CN106383191B
CN106383191B CN201610702547.5A CN201610702547A CN106383191B CN 106383191 B CN106383191 B CN 106383191B CN 201610702547 A CN201610702547 A CN 201610702547A CN 106383191 B CN106383191 B CN 106383191B
Authority
CN
China
Prior art keywords
urine
tandem mass
content
mass spectrometry
liquid chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610702547.5A
Other languages
Chinese (zh)
Other versions
CN106383191A (en
Inventor
胡清源
侯宏卫
王红娟
张小涛
陈欢
刘勇
王安
刘彤
韩书磊
付亚宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Institutes of Physical Science of CAS
National Tobacco Quality Supervision and Inspection Center
Original Assignee
Hefei Institutes of Physical Science of CAS
National Tobacco Quality Supervision and Inspection Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Institutes of Physical Science of CAS, National Tobacco Quality Supervision and Inspection Center filed Critical Hefei Institutes of Physical Science of CAS
Priority to CN201610702547.5A priority Critical patent/CN106383191B/en
Publication of CN106383191A publication Critical patent/CN106383191A/en
Application granted granted Critical
Publication of CN106383191B publication Critical patent/CN106383191B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine, it is characterized by: being that urine sample is introduced directly into liquid chromatogram-electrospray ionisation-tandem mass spectrograph to be measured after diluting, using quantified by external standard method analyte, the contents level of D-VB5 in urine can quickly, be accurately detected.The present invention is the measuring method of D-VB5 content in completely new urine, tandem mass spectrometry preferably improves the selectivity and accuracy of method, the quantitative limit of D-VB5 is respectively 1.54 ng/mL, and the rate of recovery range of method is 87.9-95.3%, RSD < 13.0%.By chromatographic column and the selection and optimization of elution requirement, chromatographic separation process is preferably improved, shortens the time of chromatography, is 8 min.

Description

The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine
Technical field:
The invention belongs to the physical and chemical inspection technical fields of urine, specifically a kind of to use liquid chromatogram-electrospray ionisation- The method that tandem mass spectrometer measures D-VB5 content in urine.
Background technique:
D-VB5 is the precursor of coacetylase (CoA), and CoA is the biologically active form that it is functioned, and is produced in substance containing carbon skeleton Pantothenic acid participation is both needed in raw energy and much cyto-architectural formation, insufficient or physiological status change of ingesting can cause pantothenic acid to lack It is weary.Pantothenic acid shortage is suppressed the reaction for needing CoA, mainly influences fatty acid metabolism, is suppressed fatty acid beta oxidation, Fatty acid oxidation especially in peroxisome is significantly suppressed, and can lead to hyperlipidemia etc., and serious person can produce brain damage Evil.In addition, pantothenic acid have lipoid peroxidization resistant, to by lipid peroxidation injury cell and rat have well protect Shield effect, it may be possible to free radical be removed by CoA form or CoA promotes phosphatide synthesis to promote to repair.It detects general in urine Acid content can be used for evaluating individual for the utilization power of nutriment, have for evaluation human body trophic level and health status There is certain meaning.
Currently, the test method of D-VB5 content mainly has High Performance Liquid Chromatography with Fluorescence Detection (HPLC-FL) in urine The method of post column derivatization is built using isotope reverse ion with liquid chromatography-mass spectrometry (LC-MS), such as Fukuwatari The measuring method of D-VB5 content in urine is found, method is quantitatively limited to 32.5 μ g/mL;Heudi etc. establishes D- in urine The LC-MS method of pantothenic acid content, urine are tested and analyzed after simple centrifugation, dilution, and the detection of method is limited to 0.1 μ G/mL, LC-MS/MS have highly sensitive, highly selective, and that D-VB5 content in urine is measured using LC-MS/MS method It has not been reported.
Summary of the invention:
The purpose of the present invention is intended to overcome prior art defect, establishes a kind of simple, quick, selectivity is good measurement urine The LC-MS/MS method of middle D-VB5 content, this method can quickly, accurately detect the content of D-VB5 in urine, and measurement result is quasi- Really, measurement interference is few.
The purpose of the present invention is achieved through the following technical solutions:
The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine, specifically includes following processing step:
A, urine is thawed at room temperature, after centrifugation, then pipettes 100 μ L urines in the volumetric flask of 10 mL;
B, it with the aqueous formic acid constant volume of volume ratio 0.1%, is uniformly mixed, then pipettes the color that about 1 mL is put into 1.8 mL It composes in bottle, is analyzed to Liquid Chromatography-Tandem Mass Spectrometry;
C, standard working solution is prepared: preparing the D-VB5 standard working solution of various concentration with 0.1% aqueous formic acid;
D, liquid chromatography-tandem mass spectrometry (LC-MS/MS) measures, and draws the standard work of above-mentioned prepared various concentration Solution, injects LC-MS/MS system, and the linear equation of D-VB5 is y=3.84e3x+7.71 e3, wherein Y represents the peak of analyte Area, X indicate the concentration of target analytes in sample, and related coefficient is greater than 0.999, is measured, measures to sample prepare liquid The peak area of analyte substitutes into unary linear regression equation, acquires the content of analyte in sample prepare liquid.
The D-VB5 standard working solution concentration is respectively 3.6,6,30,60,120,240 and 360 ng/mL.
In Step d, liquid phase chromatogram condition are as follows: Waters ACQUITY UPLC HSS T3 chromatographic column, specification 100 The mm of mm × 2. 1,1.8 μm, mobile phase: solvent A: 0.1% aqueous formic acid and solvent B:0.1% formic acid acetonitrile solution flow Phase flow velocity be 200 μ L/min, condition of gradient elution: 0-1 min, 5%B-5%B;1-5 min, 5%B-100%B;5-6 min, 100%B;6-6.3 min, 100%B-5%B;6.3-8 min, 5%B, analysis time is 8 min, and sample volume is 5 μ L.
In Step d, the condition of tandem mass spectrum detector: electric spray ion source, multiple-reaction monitoring cation scanning mode; Electron spray voltage: 5500V, atomization gas: 30 psi, gas curtain gas: 40 psi, auxiliary heating gas: 30 psi, injection voltage: 10 V, residence time: 100 ms;The selected quota ion pair of D-VB5 is respectively 220.3 → 90.1 and 220.3 → 184.3.
The range of linearity and detection limit of the method for the present invention:
Prepare series standard curve with the urine that blank mixes, D-VB5 standard working solution concentration is respectively 3.6,6, 30,60,120,240 and 360 ng/mL.Compound it is linear good, related coefficient is all larger than 0.999.Utilize the side of signal-to-noise ratio Method calculates quantitative limit and detection limit, and the corresponding concentration of 10 times of signal-to-noise ratio of target peak is quantitative limit, and the corresponding concentration of 3 times of signal-to-noise ratio is Detection limit.The quantitative limit of D-VB5 is respectively 1.54 ng/mL.
The method of the present invention recovery of standard addition and repeatability:
Using matrix plus the rate of recovery of the method measuring method of standard items.Five urine specimens are chosen, are surveyed after mixing Its fixed content is 72.35 ng/mL, chooses low, medium and high three pitch-based spheres and standard items are added, each concentration does 6 weights in parallel It is multiple, the rate of recovery and precision (in terms of relative standard deviation (RSD)) of method are obtained, is shown in Table 1, the rate of recovery range of method is 87.9-95.3%, RSD < 13.0%.
The rate of recovery and precision (n=6) of 1 method of table
Method of the invention overcomes the low deficiency of prior art sensitivity, for urine specimen to the correlation of LC-MS/MS Testing conditions are optimized, and mainly optimize ion source condition, chromatographic column and flow visualizing.Compared with prior art originally Inventive method has following excellent results:
1. LC-MS/MS sensitivity is higher compared with HPLC and LC-MS, the detection of D-VB5 is limited to 0.46 ng/mL, LC- MS method is 100 ng/mL, is greatly improved compared with the Sensitivity disclosed by the documents method.
2. this method pre-treatment is easy, complicated solid phase extraction procedure is needed not move through, analysis throughput can be improved, have Quickly, accurately, high sensitivity and reproducible advantage.
To sum up, the present invention is the measuring method of D-VB5 content in completely new urine, and tandem mass spectrometry preferably improves The selectivity and accuracy of method, the quantitative limit of D-VB5 are respectively 1.54 ng/mL, and the rate of recovery range of method is 87.9- 95.3%, RSD < 13.0%.By chromatographic column and the selection and optimization of elution requirement, chromatographic separation process is preferably improved, The time of chromatography is shortened, is 8 min.
Detailed description of the invention
The chromatogram of Fig. 1 D-VB5.
Specific embodiment
The present invention is described further below in conjunction with example, but is not the limitation present invention.
Example 1:
1. instrument and reagent: 1200 liquid chromatogram of Agilent (Agilent company of the U.S.) is furnished with G1329A automatic sampling Device, G1311A quaternary mixing pump and G1316A, column oven;The triple quadrupole tandem mass spectrometers of API 4000 (U.S.'s application biology System house), it is furnished with electric spray ion source (ESI) and 1.5 software data processing system of analyst.
D-VB5 standard items are to be greater than 98% purchased from Shanghai branch company, Wuhan Yi Tai Science and Technology Ltd. purity;Formic acid and Acetonitrile is chromatographically pure, and water used is deionized water in experiment.
2. sample treatment: urine is thawed at room temperature, then pipettes 100 μ L urines in the volumetric flask of 10 mL, is used 0.1% aqueous formic acid constant volume is uniformly mixed, then pipettes about 1 mL and be put into the chromatogram bottle of 1.8 mL, to LC-MS/MS It is analyzed.
3. measuring method: drawing standard solution, (standard working solution concentration is respectively 3.6,6,30,60,120,240 and 360 ng/mL) and dilute filtration after each 5 μ L of sample, injection LC-MS/MS system carry out separation analysis, measure D- in sample The content of pantothenic acid.
Example 2: measuring method described in embodiment 1 is pressed, 8 urine specimens is chosen, measures the content such as table 2 of its D-VB5 It is shown.
The contents level (μ g/mL) of D-VB5 in 2 sample of table
Serial number D-VB5 Serial number D-VB5
1 15.6 5 7.99
2 10.7 6 11.5
3 8.94 7 12.0
4 6.88 8 20.1

Claims (1)

1. the Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine, it is characterised in that: the following steps are included:
A, urine is thawed at room temperature, after centrifugation, then pipettes 100 μ L urines in the volumetric flask of 10 mL;
B, with 0.1% aqueous formic acid constant volume, be uniformly mixed, then pipette about 1 mL and be put into the chromatogram bottle of 1.8 mL, to Liquid Chromatography-Tandem Mass Spectrometry is analyzed;
C, standard working solution is prepared: preparing the D-VB5 standard working solution of various concentration, concentration with 0.1% aqueous formic acid The ng/mL of respectively 3.6,6,30,60,120,240 and 360;
D, liquid chromatography-tandem mass spectrometry (LC-MS/MS) measures, and draws the standard working solution of above-mentioned prepared various concentration, LC-MS/MS system is injected, the linear equation of D-VB5 is y=3.84e3x+7.71 e3, wherein y represents the peak area of analyte, x Indicate the concentration of target analytes in sample, related coefficientrGreater than 0.9993, sample prepare liquid is measured, measures analysis The peak area of object substitutes into unary linear regression equation, acquires the content of analyte in sample prepare liquid;
Liquid phase chromatogram condition: using ACQUITY UPLC HSS T3 chromatographic column, specification 100 mm × 2. 1 mm, and 1.8 μm, Mobile phase: solvent A: 0.1% aqueous formic acid, solvent B:0.1% formic acid acetonitrile solution, flow rate of mobile phase are 200 μ L/min, ladder Spend elution requirement: 0-1 min, 5%B-5%B;1-5 min, 5%B-100%B;5-6 min, 100%B;6-6.3 min, 100%B-5% B;6.3-8 min, 5%B;Analysis time is 8 min, and sample volume is 5 μ L;
Tandem mass spectrum detector condition: electric spray ion source, multiple-reaction monitoring cation scanning mode;Electron spray voltage: 5500V, atomization gas: 30 psi, gas curtain gas: 40 psi, auxiliary heating gas: 30 psi inject voltage: 10 V, when being resident Between: 100 ms;The selected quota ion pair of D-VB5 is respectively 220.3 → 90.1 and 220.3 → 184.3.
CN201610702547.5A 2016-08-23 2016-08-23 The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine Active CN106383191B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610702547.5A CN106383191B (en) 2016-08-23 2016-08-23 The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610702547.5A CN106383191B (en) 2016-08-23 2016-08-23 The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine

Publications (2)

Publication Number Publication Date
CN106383191A CN106383191A (en) 2017-02-08
CN106383191B true CN106383191B (en) 2019-11-01

Family

ID=57916845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610702547.5A Active CN106383191B (en) 2016-08-23 2016-08-23 The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine

Country Status (1)

Country Link
CN (1) CN106383191B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014520265A (en) * 2011-06-16 2014-08-21 ベイラー リサーチ インスティテュート Analysis of total homocysteine and methylmalonic acid in plasma obtained from a plasma separation device (PSD) by LC-MS / MS
KR101513872B1 (en) * 2012-05-21 2015-04-21 한국콜마주식회사 Method for simultaneous analysis of vitamins by using liquid chromatography
WO2014150900A1 (en) * 2013-03-15 2014-09-25 Baylor Research Institute Methods and compositions for enhanced analyte detection from blood
CN104614479B (en) * 2015-01-30 2016-06-22 北京市营养源研究所 A kind of detection method of food vitamins
CN104730190B (en) * 2015-03-04 2017-01-04 苏州源泽生物技术有限公司 Measure the method for multiple water-soluble vitamin content in the middle of food or health product simultaneously

Also Published As

Publication number Publication date
CN106383191A (en) 2017-02-08

Similar Documents

Publication Publication Date Title
CN111175394B (en) Method for detecting plasma catecholamine and metabolite thereof by liquid chromatography-tandem mass spectrometry
CN102147397B (en) Method for detecting taurine in functional beer by adopting high performance liquid chromatography (HPLC)
CN104359998B (en) A kind of gas chromatography tandem mass spectrometry detects the method for methyl mesylate
CN109406690B (en) Method for detecting related substances in chloral hydrate
CN105891364A (en) Method and kit for detecting melatonin in saliva with HPLC-MS/MS (high performance liquid chromatography-tandem mass spectrometry) technology
CN105675788A (en) Method and kit for detecting progesterone and testosterone in saliva through high performance liquid chromatography-tandem mass spectrometry technique
CN102980968A (en) Liquid chromatogram tandem mass spectrum measuring method for creatinine in urine
CN108760920B (en) Method for determining residual quantity of cyazofamid and metabolites thereof based on HPLC-MSMS method
CN105158372B (en) Method for determining urocanic acid and ethyl ester thereof in cosmetics
CN105092733B (en) The reduction method and apparatus of fixedness buffer salt content in LC MS testers
Lv et al. On-line galvanic cell generated electrochemiluminescence determination of acyclovir based on the flow injection sampling
CN105548402A (en) Kit for detecting 8-hydroxyl deoxyguanosine and 8-hydroxyl guanosine in urine through high performance liquid chromatography tandem mass spectrometry technology
CN105527368A (en) Method for detecting 8-hydroxydeoxyguanosine and 8-hydroxyguanosine in urine by high-performance liquid chromatography tandem mass spectrometry technology
CN106383191B (en) The Liquid Chromatography-Tandem Mass Spectrometry measuring method of D-VB5 content in a kind of urine
CN110361485A (en) Oxcarbazepine monitor drug concentration kit and its detection method in a kind of blood
CN104391071A (en) Analysis method of 8-hydroxy deoxyguanosine, 8-hydroxy guanosine and 8-iso-prostaglandin F2alpha in urine of human body
CN102565252B (en) Method for detecting content of homocysteine in blood or urine
CN104991027B (en) The method for reducing fixedness buffer salt content in LC MS testers
CN109298092B (en) HPLC method for detecting content of methylsulfonyl chloride in industrial waste liquid
CN116124905A (en) Method for detecting short chain fatty acid in mouse plasma, feces or tissue sample
CN113917008A (en) Application of product for detecting metabolite level in urine by mass spectrometry in preparation of product for early evaluation of intestinal polyp and colorectal cancer
CN113466396A (en) Method for detecting migration amount of plasticizer in skin contact material
CN105699575A (en) Method and kit for testing cortisol in saliva by efficient liquid chromatogram and tandem mass spectrometry combination technology
CN103512991A (en) Automatic on-line analysis method for acrylamide mercapt uric acid metabolites in urine
CN103115993B (en) The Liquid Chromatography-Tandem Mass Spectrometry assay method of CEMA and HEMA in a kind of urine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Hu Qingyuan

Inventor after: Fu Yaning

Inventor after: Hou Hongwei

Inventor after: Wang Hongjuan

Inventor after: Zhang Xiaotao

Inventor after: Chen Huan

Inventor after: Liu Yong

Inventor after: Wang An

Inventor after: Liu Tong

Inventor after: Han Shulei

Inventor before: Hu Qingyuan

Inventor before: Hou Hongwei

Inventor before: Zhang Xiaotao

Inventor before: Chen Huan

Inventor before: Liu Yong

Inventor before: Wang An

Inventor before: Liu Tong

Inventor before: Han Shulei

Inventor before: Fu Yaning

GR01 Patent grant
GR01 Patent grant